EP4199920A4 - Im mund dispergierbare filmformulierungen mit hohen dosen von eletriptan - Google Patents

Im mund dispergierbare filmformulierungen mit hohen dosen von eletriptan Download PDF

Info

Publication number
EP4199920A4
EP4199920A4 EP21858726.9A EP21858726A EP4199920A4 EP 4199920 A4 EP4199920 A4 EP 4199920A4 EP 21858726 A EP21858726 A EP 21858726A EP 4199920 A4 EP4199920 A4 EP 4199920A4
Authority
EP
European Patent Office
Prior art keywords
eletriptan
high doses
film formulations
orodispersible film
orodispersible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21858726.9A
Other languages
English (en)
French (fr)
Other versions
EP4199920A1 (de
Inventor
Serdar Unlu
Mustafa KOKTURK
Filiz Demir
Yasemin SAHIN
Mehmet Malkoc
Cansu MAGAZACI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ali Raif Ilac Sanayi AS
Original Assignee
Ali Raif Ilac Sanayi AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Raif Ilac Sanayi AS filed Critical Ali Raif Ilac Sanayi AS
Publication of EP4199920A1 publication Critical patent/EP4199920A1/de
Publication of EP4199920A4 publication Critical patent/EP4199920A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP21858726.9A 2020-08-19 2021-06-18 Im mund dispergierbare filmformulierungen mit hohen dosen von eletriptan Pending EP4199920A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2020/13084A TR202013084A1 (tr) 2020-08-19 2020-08-19 Yüksek dozda eletriptan i̇çeren ağizda eri̇yen fi̇lm formülasyonlari
PCT/TR2021/050624 WO2022039692A1 (en) 2020-08-19 2021-06-18 Orodispersible film formulations comprising high doses of eletriptan

Publications (2)

Publication Number Publication Date
EP4199920A1 EP4199920A1 (de) 2023-06-28
EP4199920A4 true EP4199920A4 (de) 2024-10-02

Family

ID=80350558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21858726.9A Pending EP4199920A4 (de) 2020-08-19 2021-06-18 Im mund dispergierbare filmformulierungen mit hohen dosen von eletriptan

Country Status (3)

Country Link
EP (1) EP4199920A4 (de)
TR (1) TR202013084A1 (de)
WO (1) WO2022039692A1 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374448A1 (de) * 2010-04-06 2011-10-12 Labtec GmbH Formulierung eines Films zur oralen Verabreichung
US20120148689A1 (en) * 2007-06-19 2012-06-14 Todd Maibach Film comprising active drugs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120148689A1 (en) * 2007-06-19 2012-06-14 Todd Maibach Film comprising active drugs
EP2374448A1 (de) * 2010-04-06 2011-10-12 Labtec GmbH Formulierung eines Films zur oralen Verabreichung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PALLAVI K. ET AL: "FORMULATION AND EVALUATION OF FAST DISSOLVING FILMS OF ELETRIPTAN HYDROBROMIDE", INTERNATIONAL JOURNAL OF CURRENT PHARMACEUTICAL RESEARCH, vol. 9, no. 2, 1 March 2017 (2017-03-01), pages 59, XP055908654, Retrieved from the Internet <URL:http://innovareacademics.in/journals/index.php/ijcpr/article/viewFile/17386/9680> DOI: 10.22159/ijcpr.2017v9i2.17386 *
See also references of WO2022039692A1 *

Also Published As

Publication number Publication date
EP4199920A1 (de) 2023-06-28
TR202013084A1 (tr) 2022-03-21
WO2022039692A1 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
CY1118059T1 (el) Συνθεσεις αντιλοιμωδων βασει λιπιδιων για αγωγη πνευμονικων λοιμωξεων
EP3934633A4 (de) Zusammensetzungen und verwendungsverfahren mit substanzen mit neuralen plastizitätswirkungen, die in nicht-psychedelischen/psychotomimetischen dosierungen und formulierungen verabreicht werden
JOP20200154A1 (ar) مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات sos1
CY1116123T1 (el) Σκευασμα ιβανδρονατης υψηλης δοσης
CY1111726T1 (el) Φαρμακευτικες συνθεσεις για τη θεραπεια του ασθματος
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CY1107894T1 (el) Προφαρμακα αναλογων gaba, συνθεσεις και χρησεις αυτων
ATE418324T1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
MA55033A (fr) Formulation d&#39;anticorps thérapeutique
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
AR018862A1 (es) Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion
EP3773900A4 (de) Hinokitiol-analoga, verfahren für die zubereitung und pharmazeutische zusammensetzungen daraus
EP3867271A4 (de) Formulierungen von anti-rsv-antikörpern und verfahren zu deren verwendung
EA202192199A1 (ru) Композиции, содержащие коричную кислоту, и способы их применения
CY1116274T1 (el) Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας
JOP20250048A1 (ar) تركيبات للإعطاء عن طريق الفم
EP4199920A4 (de) Im mund dispergierbare filmformulierungen mit hohen dosen von eletriptan
EP4355259A4 (de) Subgingivale medikamentenabgabeschale
EP3946277A4 (de) Oral zerfallende pharmazeutische zusammensetzungen von apixaban
SE0200657D0 (sv) Novel Formulation
EP4297590A4 (de) Orale dosierzusammensetzungen von tributyrin zur therapeutischen erzeugung von butyrat im darm
EP4259713A4 (de) Formulierungen zur abgabe von bioaktiven mitteln
JOP20240074A1 (ar) تركيبات إنزالوتاميد سائلة فموية
MA71620A (fr) Formulations d&#39;anticorps anti-tl1a

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240904

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/06 20060101ALI20240829BHEP

Ipc: A61K 9/70 20060101ALI20240829BHEP

Ipc: A61K 31/404 20060101AFI20240829BHEP